Notices of Judgment Under the Federal Food, Drug, and Cosmetic Act. ... Drugs and Devices, 5501-7120. izdevums |
No grāmatas satura
1.–5. rezultāts no 100.
28. lappuse
... statement of the quantity of contents ; Sec- tion 502 ( e ) , the article was a drug not designated solely by a name recognized in an official compendium , and its label failed to bear ( 1 ) the common or usual name of the drug ; and ...
... statement of the quantity of contents ; Sec- tion 502 ( e ) , the article was a drug not designated solely by a name recognized in an official compendium , and its label failed to bear ( 1 ) the common or usual name of the drug ; and ...
33. lappuse
... statement " Timed Disintegration Capsule Each Capsule Contains 75 Mg . Pyrilamine Maleate Released gradually and equivalent to 3 doses of 25 mg . over a period of approximately 8 hours " was false and misleading as applied to a product ...
... statement " Timed Disintegration Capsule Each Capsule Contains 75 Mg . Pyrilamine Maleate Released gradually and equivalent to 3 doses of 25 mg . over a period of approximately 8 hours " was false and misleading as applied to a product ...
34. lappuse
... statement " Each Capsule contains *** Salicylamide 2 % grains " was false and misleading as applied to a product which did not con- tain salicylamide , and the label statement " For the relief of symptoms of *** sinusitis " was false ...
... statement " Each Capsule contains *** Salicylamide 2 % grains " was false and misleading as applied to a product which did not con- tain salicylamide , and the label statement " For the relief of symptoms of *** sinusitis " was false ...
39. lappuse
... statements . ...... . 42 Drugs for veterinary use . 55555 50 50 * For presence of a habit - forming substance without warning statement , see No. 5584 ; omission of , or unsatisfactory , ingredients statements , Nos . 5584 , 5594 , 5607 ...
... statements . ...... . 42 Drugs for veterinary use . 55555 50 50 * For presence of a habit - forming substance without warning statement , see No. 5584 ; omission of , or unsatisfactory , ingredients statements , Nos . 5584 , 5594 , 5607 ...
40. lappuse
... statement of the quantity of con- tents ; Section 502 ( d ) , the article contained a chemical derivative of barbituric acid , and its label failed to bear the name , and quantity or proportion of such derivative and in juxtaposition ...
... statement of the quantity of con- tents ; Section 502 ( d ) , the article contained a chemical derivative of barbituric acid , and its label failed to bear the name , and quantity or proportion of such derivative and in juxtaposition ...
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
ACCOMPANYING LABELING acid actionable adequate and effective Administration alleged amount amphetamine sulfate tablets answer application arthritis article contained false article failed blood body bottles boxes btls bulk Calif cartoned cause CHARGE claimant contents Corp corporation Cosmetic counts court ctns Default-destruction defendant devices Dexedrine differed diseases dispensed dispensed once DISPOSITION Dist District Drug DRUGS AND DEVICES effective treatment entered Examination failed to bear false and misleading Federal Food Formula Government Guilty Health held for sale individually infections INFORMATION FILED interstate commerce involve issued judgment label containing label failed Laboratories Leaflets entitled LIBELED manufacturer mineral misbranded misleading representations motion Natural Office Pharmacy placed PLEA prescription prevent probation proceedings Products providing purported QUANTITY reducing relabeled remedies requests RESULTS OF INVESTIGATION rheumatism Royal SHIPPED showed skin sodium capsules standard statement strength Supplement tablets containing tion United vials vibrating violation Vitamin warning York
Populāri fragmenti
208. lappuse - new drug" means (1) any drug the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety of...
148. lappuse - The several circuit courts of the United States are hereby invested with jurisdiction to prevent and restrain violations of this act; and it shall be the duty of the several district attorneys of the United States, in their respective districts, under the direction of the Attorney General, to institute proceedings in equity to prevent and restrain such violations.
208. lappuse - ... fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the article to which the labeling relates under the conditions of use prescribed in the labeling thereof or under such conditions of use as are customary or usual.
146. lappuse - Any party may serve upon any adverse party written interrogatories to be answered by the party served or, if the party served is a public or private corporation or a partnership or association, by any officer or agent, who shall furnish such information as is available to the party.
289. lappuse - If any word, statement or other information required by or under authority of this Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
107. lappuse - Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users...
265. lappuse - If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count...
208. lappuse - ... advertisement fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the...
255. lappuse - ... because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, is not safe for use except under the supervision of a practitioner licensed by law to administer such drug...
144. lappuse - Such legislation dispenses with the conventional requirement for criminal conduct — awareness of some wrongdoing. In the interest of the larger good it puts the burden of acting at hazard upon a person otherwise innocent but standing in responsible relation to a public danger.